Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the HomeLox portable liquid oxygen system. The innovative system enables oxygen users to generate and store the liquid form of oxygen in the home setting. The HomeLox system offers users the long-lasting and lightweight characteristics of traditional liquid systems, while freeing them from difficulties of filling and dependence on deliveries associated with conventional systems.
Home oxygen is a critical, life-sustaining medical treatment prescribed to nearly 1.5 million Medicare patients annually who suffer from respiratory illnesses such as chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/philips/45648/
Join P&G and the Children’s Safe Drinking Water Program (CSDW) to provide clean drinking water to children in need.
GIVE HEALTH partners with the non-profit P&G Children’s Safe Drinking Water Program (CSDW) to provide PUR packets in developing countries. These packets, developed by P&G and the U.S. Centers for Disease Control, use some of the same ingredients as municipal water systems to remove pollutants from contaminated water. Since 2004, CSDW has provided more than 3 billion liters of water to children in need in over 60 countries.
To view Multimedia News Release, go to http://www.multivu.com/players/English/49448-PG-myGive-Campaign/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Close-Up TV News recognizes the NYU Langone Weight Management Program as the country’s premier surgical weight loss facility
The term “morbid obesity” is generally defined as being 100 lbs over the ideal weight or having a Body Mass Index between 35 and 40. Morbid obesity significantly can increase a patient’s risk for diabetes, heart disease and high blood pressure. Unfortunately, for these patients, diet and exercise alone cannot offer a practical solution.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/thinforlife/50245/
More than 24 million Americans currently have asthma. Every day, 11 people in the United States die from asthma and the disease accounts for one-quarter of all emergency room visits each year. For many people with asthma, their home may be part of the problem.
Any house or apartment can contain a variety of asthma “triggers,” which can include allergens and irritants – such as dust mites, mold, pet dander and strong fumes or odors – that can negatively affect someone with asthma.
To view Multimedia News Release, go to http://www.multivu.com/players/English/49320-Merck-Asthma-Awareness/
A new survey from the nonprofit Gout & Uric Acid Education Society (GUAES) highlights an alarming awareness gap among Americans regarding the risk factors for gout, a chronic, potentially disabling form of arthritis which now affects an estimated 8.3 million Americans. Among the survey findings are that only one in 10 Americans correctly cited cardiovascular disease as a risk factor for gout, while only one in three Americans correctly reported that obesity is a risk factor, and less than one in five reported that diabetes and kidney disease are risk factors. GUAES released the survey findings in advance of its annual Gout Awareness Day on May 22.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gouteducation/49664/
Landmark public health campaign DRIVE4COPD announced today that Tim Wright was chosen from more than 150 entries as the winner of the Tune Up for COPD Songwriting Competition. DRIVE4COPD Celebrity Ambassadors Billy Ray Cyrus and Patty Loveless were among the judges for the competition, launched in partnership with the Country Music Association (CMA), which challenged Americans to create a new DRIVE4COPD song to help raise awareness of chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://www.multivu.com/players/English/48274-boehringer-ingelheim-tuneupforcopd/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
The View’s Elisabeth Hasselbeck hosted the eighth-annual More Magazine | Fitness Magazine Women’s Half-Marathon in Central Park on April 3rd. More and Fitness magazines in partnership with New York Road Runners, welcomed nearly 10,000 runners for the biggest women’s-only half marathon in the country. Hasselbeck also participated in the race, running her first half marathon with her own Team Nogii to raise money for Celiac Disease research, an autoimmune disease from which she suffers. Hasselbeck finished with a time of 1:44:32.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/more-fitnessmagazine/48499/
Beginning in mid-March, the AARP/Walgreens Wellness Tour will once again travel the country, embarking on a ten-month tour to provide an expected $14 million worth of free health tests. The national mobile tour will conduct free health-testing events in communities throughout the United States and Puerto Rico. The free tests—which include total cholesterol levels, blood pressure, bone density, glucose levels, waist circumference and body mass index—are valued at $100 per person and may help provide adults with a critical foundation for early disease detection and prevention.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/walgreens/48029/
Living with tobacco-related diseases and the devastating effects of tobacco use take center stage in the latest creative from truth®, the nation’s largest smoking prevention campaign for youth.
While the American public may commonly connect tobacco use with often fatal diseases such as lung cancer and heart attacks, an estimated 8.6 million people in the United States are living with serious illnesses attributed to smoking. For many, it means suffering on a daily basis, and drastic changes from their pre-disease lifestyles.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/legacyforhealth/47243/
Jewelry Television® (JTV) is showing its support for the American Heart Association’s Go Red For Women® movement by launching “Love Your Heart,” a comprehensive, multimedia initiative aimed at raising awareness and educating viewers about the risks of heart disease.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/jewelrytelevision/46001/
